(A) Screening candidate chemoreceptors for defects in Ca2+ aversion. n=4—12.
(B) Dose-dependent avoidance of Ir mutants to Ca2+. n=4.
(C) Rescue of Ca2+ avoidance defects in Ir25a2 by expressing UAS-Ir25a using the indicated GAL4, or the Ir25a+ genomic transgene (gen. Ir25a). n=5—12.
(D) Rescue of Ca2+ avoidance deficits in Ir62a1 by expressing UAS-Ir62a using the indicated GAL4. n=4.
(E) Rescue of Ca2+ avoidance impairments in Ir76b1 by expressing UAS-Ir76b using the indicated GAL4. n=5—13. Error bars represent SEMs. Asterisks in A and B indicate significant differences from controls (*P < 0.05, **P<0.01) using ANOVA with Scheffe’s post hoc test. The black and red asterisks in C—E indicate significant differences from the controls and mutants, respectively (*P < 0.05, **P<0.01), using ANOVA with Scheffe’s post hoc test.